What are the different types of HIV drugs?

Several different classes of drugs of human immunodeficiency virus (HIV) are on the market to treat patients infected with this virus. These include reverse transcript inhibitors, protease inhibitors and fusion inhibitors. The physician determines which HIV medicines are best for the patient after thorough evaluation and discussion with the patient about the targets of treatment. Because it is not possible to eradicate the virus from the body, the purpose of treatment is to suppress the replication to prevent the onset of the syndrome of the obtained immune deficiency (AIDS). This also prevents the development of complications in patients with advanced HIV infections. Some act by preventing the virus from entering and kidnapping a cell with its genetic material. Others allow the virus to enter the cells, but to create blocks of injury when they try to reproduce.Virus thought drugs as part of its genetic code and create defective replicas with drug inserts.

There are several types of reverse transcriptase inhibitors. "Nukes" are nucleoside inhibitors or nucleotide reverse transcriptases (NSTIS and NRTI). ThyThe drugs are disrupted by the enzyme reverse transcriptase, which must replicate the virus. "Non-Nes" or non-nucleoside inhibitors of reverse transcriptases (NNRTIs) are another example. The effectiveness of the drug may depend on the type of HIV that the patient has; The virus comes in several subtypes that are endemic in different regions.

Protease inhibitors disrupt protease, other enzymes that the virus must make copies of themselves, while the merger inhibitors or inhibitors prevent HIV from entering cells at all. These HIV drugs do not give the virus a chance to start replicating the enemy environment inside the body. Another HIV group of medicines known as integrame inhibitors also makes it difficult to enter and connect with cells to prevent cell colonization and increase the patient's viral burden.

In antiretroviral therapy for HIV, the doctor usually prescribes medicines from two different classes to target the virus of moreangles. Patients must follow the treatment regimen. It may be necessary to adjust the doses regularly to meet the changing health needs of the patient. Another problem with HIV medicines is the question of coinfects such as tuberculosis and hepatitis C, which can complicate treatment. These infections may require changes in drug mode or more careful monitoring.